Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2009

Mice lacking mannose 6-phosphate uncovering enzyme activity
have a milder phenotype than mice deficient for Nacetylglucosamine-1-phosphotransferase activity
Marielle Boonen
Washington University School of Medicine in St. Louis

Peter Vogel
Lexicon Pharmaceuticals, Inc.

Kenneth A. Platt
Lexicon Pharmaceuticals, Inc.

Nancy Dahms
Medical College of Wisconsin

Stuart Kornfeld
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Part of the Medicine and Health Sciences Commons

Recommended Citation
Boonen, Marielle; Vogel, Peter; Platt, Kenneth A.; Dahms, Nancy; and Kornfeld, Stuart, ,"Mice lacking
mannose 6-phosphate uncovering enzyme activity have a milder phenotype than mice deficient for Nacetylglucosamine-1-phosphotransferase activity." Molecular Biology of the Cell. 20,20. 4381-4389.
(2009).
https://digitalcommons.wustl.edu/open_access_pubs/412

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

Molecular Biology of the Cell
Vol. 20, 4381– 4389, October 15, 2009

Mice Lacking Mannose 6-Phosphate Uncovering Enzyme
Activity Have a Milder Phenotype than Mice Deficient for
N-Acetylglucosamine-1-Phosphotransferase Activity
Marielle Boonen,* Peter Vogel,† Kenneth A. Platt,† Nancy Dahms,‡
and Stuart Kornfeld*
*Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110;
†
Department of Pathology, Lexicon Pharmaceuticals, Inc., The Woodlands, TX 77381; and ‡Department of
Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226
Submitted May 14, 2009; Revised July 28, 2009; Accepted August 17, 2009
Monitoring Editor: Sean Munro

The mannose 6-phosphate (Man-6-P) lysosomal targeting signal on acid hydrolases is synthesized by the sequential action
of uridine 5ⴕ-diphosphate-N-acetylglucosamine: lysosomal enzyme N-acetylglucosamine-1-phosphotransferase (GlcNAc1-phosphotransferase) and GlcNAc-1-phosphodiester ␣-N-acetylglucosaminidase (“uncovering enzyme” or UCE). Mutations in the two genes that encode GlcNAc-1-phosphotransferase give rise to lysosomal storage diseases (mucolipidosis
type II and III), whereas no pathological conditions have been associated with the loss of UCE activity. To analyze the
consequences of UCE deficiency, the UCE gene was inactivated via insertional mutagenesis in mice. The UCE ⴚ/ⴚ mice
were viable, grew normally and lacked detectable histologic abnormalities. However, the plasma levels of six acid
hydrolases were elevated 1.6- to 5.4-fold over wild-type levels. These values underestimate the degree of hydrolase
hypersecretion as these enzymes were rapidly cleared from the plasma by the mannose receptor. The secreted hydrolases
contained GlcNAc-P-Man diesters, exhibited a decreased affinity for the cation-independent mannose 6-phosphate
receptor and failed to bind to the cation-dependent mannose 6-phosphate receptor. These data demonstrate that UCE
accounts for all the uncovering activity in the Golgi. We propose that in the absence of UCE, the weak binding of the acid
hydrolases to the cation-independent mannose 6-phosphate receptor allows sufficient sorting to lysosomes to prevent the
tissue abnormalities seen with GlcNAc-1-phosphotranferase deficiency.

INTRODUCTION
In higher eukaryotes, mannose 6-phosphate (Man-6-P) monoesters on newly synthesized acid hydrolases serve as
high-affinity ligands for binding to Man-6-P receptors
(MPRs) in the trans-Golgi network (TGN). This is followed
by packaging of the receptor–ligand complexes into transport carriers that deliver the acid hydrolases to endosomes
where they are released and subsequently incorporated into
lysosomes (for reviews, see Ghosh et al., 2003; Braulke and
Bonifacino, 2009). The generation of the Man-6-P recognition
signal is a two step process. First, uridine 5⬘-diphosphate-N-acetylglucosamine (UDP-GlcNAc):lysosomal enzyme
N-acetylglucosamine-1-phosphotransferase (GlcNAc-1-phosphotransferase) transfers GlcNAc-P to selected mannose resiThis article was published online ahead of print in MBC in Press
(http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E09 – 05– 0398)
on August 26, 2009.
Address correspondence to: Stuart Kornfeld (skornfel@im.wustl.edu).
Abbreviations used: CD-MPR, cation-dependent mannose 6-phosphate receptor; CI-MPR, cation-independent mannose 6-phosphate receptor; GlcNAc, N-acetylglucosamine; GlcNAc-1-phosphotransferase,
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dues of the N-linked high mannose glycans on the acid
hydrolases. Then, N-acetylglucosamine-1-phosphodiester
␣-N-acetylglucosaminidase (“uncovering enzyme” or UCE or
“Nagpa”) excises the GlcNAc to form the Man-6-P monoester.
UCE is a type 1 transmembrane glycoprotein of 515 amino
acids that localizes to the TGN but cycles to the plasma membrane (Varki and Kornfeld, 1981; Kornfeld et al., 1999; Rohrer
and Kornfeld, 2001, Lee et al., 2002b). It is synthesized as an
inactive precursor that is activated upon proteolytic cleavage
by the TGN-localized endoprotease furin (Do et al., 2002).
Mutations in the two genes that encode the subunits (␣/␤
and ␥) of GlcNAc-1-phosphotransferase give rise to autosomal recessive lysosomal storage disorders (I-cell disease/
mucolipidosis [ML]-II and PseudoHurler polydystrophy/MLIII) characterized by hypersecretion of lysosomal hydrolases,
skeletal abnormalities, and psychomotor retardation (for review, see Kornfeld and Sly, 2000; Cathey et al., 2009). To
date, there have been no reports of pathological mutations in
the gene that encodes UCE. There are several potential explanations for this. There could be an alternative mechanism
for conversion of the Man-6-P diesters to monoesters. Furthermore, inactivating mutations in the UCE gene might be
very rare events. Finally, it was recently reported that repeat
domain 5 (of a total of 15 repeating domains) of the cationindependent mannose 6-phosphate receptor (CI-MPR) is
able to bind GlcNAc-P-Man diesters, although this binding
was of much lower affinity than the binding of Man-6-P
monoesters to domains 1–3 and 9 of the receptor (Chavez et
al., 2007; for review, see Dahms et al., 2008). This raises the
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Figure 1. Disruption of the UCE gene by insertional mutagenesis.
A ␤-galactosidase-Neomycin cassette (B-Geo) was inserted between
exons 4 and 8 of the gene encoding UCE (Nagpa) in mouse, by using
a targeting mutagenesis approach. The localization of the probes (5⬘and 3⬘-external) and restriction sites (XhoI-BglII) used for the Southern blot experiment (see Figure 2A), and the primers used for
genotyping the mice (see Figure 2B) are shown.

possibility that, in the absence of UCE activity, acid hydrolases bearing Man-6-P diesters might be able to bind sufficiently to the CI-MPR to allow enough trafficking to lysosomes to prevent the clinical manifestations seen with
GlcNAc-1-phosphotransferase deficiency. However, these
studies were performed in vitro; thus, it is not clear whether
this low-affinity binding to the receptor would prevent hypersecretion of acid hydrolases by cells lacking UCE activity.
Mice with a disruption of the gene encoding the ␣/␤
subunits of GlcNAc-1-phosphotransferase have very high
serum levels of acid hydrolases that lack Man-6-P monoesters (Gelfman et al., 2007; Lee et al., 2007). These mice
exhibit growth retardation, severe retinal degeneration, and
striking vacuolization of the secretory cells of several exocrine glands (Gelfman et al., 2007; Vogel et al., 2009). To
analyze the consequences of the loss of UCE activity, we
used insertional mutagenesis to inactivate the single gene encoding UCE in mice. Our results indicate that UCE accounts for
essentially all the conversion of GlcNAc-P-Man diester to monoester on newly synthesized acid hydrolases. Loss of UCE
activity induces hypersecretion of acid hydrolases but, in contrast to the loss of GlcNAc-1-phosphotransferase, there are no
detectable growth or tissue abnormalities in these mice.
MATERIALS AND METHODS
Materials
Chemicals were obtained from Sigma-Aldrich (St. Louis, MO) unless otherwise specified. Recombinant human UCE, recombinant human GlcNAc-1phosphotransferase along with human serum albumin-mannose were generously provided by Dr. W. Canfield (Genzyme, Oklahoma City, OK). The
CI-MPR affinity column (CI-MPR coupled at 0.5 mg/ml Affigel-10 matrix)
was prepared as described previously (Varki and Kornfeld, 1983). Cationdependent (CD)-MPR (soluble, glycosylation-deficient form) was expressed
in Pichia pastoris as a secreted protein, purified by pentamannosyl phosphate
agarose affinity chromatography and coupled at 0.7 mg/ml to Affigel-10
matrix, as described previously (Reddy et al., 2003). Cellgro ␣-minimal essential media (␣-MEM) and penicillin/streptomycin were obtained from Thermo
Fisher Scientific (Waltham, MA). G418 sulfate was obtained from Calbiochem
(EM Scientific, Gibbstown, NJ), and fetal calf serum (FCS) was from ISC
BioExpress (Kaysville, UT).

Generation of Mutant Nagpa (UCE) Mice
The gene that encodes UCE in mice (Nagpa) was disrupted by insertional
mutagenesis (Figure 1). The targeting vector was generated by insertion of
two Nagpa-homology domains (5⬘ and 3⬘ arms) upstream and downstream of
a ␤-galactosidase-Neomycin (B-Geo) cassette, respectively. The homology
arms were derived using long-range polymerase chain reaction (PCR) using
129/SvEvBrd embryonic stem (ES) cell (Lex-1) DNA as a template. The 3639
base pairs 5⬘ arm was generated using primers Nagpa-2 [5⬘-TAGCGGCCGCGACGCGATGGAACCATAGTCAC-3⬘] and Nagpa-1 [5⬘-ATGGCGCGCCATCTCCCATAGGTTAAGGCTGTGC-3⬘] and cloned using the TOPO (Invitrogen, Carlsbad, CA) cloning kit. The 4564-base pair 3⬘ arm was generated
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using primers Nagpa-6 [5⬘-ATGGCGCGCCGCAGCTGGTATGACGCCTTC3⬘] and Nagpa-7 [5⬘-CTAAGCTTCAGAAAGGGCGCTCTCAGAGTAAC-3⬘]
and cloned using the TOPO cloning kit. The 5⬘ arm was excised from the
holding plasmid by using NotI and AscI. The 3⬘ arm was excised from the
holding plasmid by using AscI and HindIII. The arms were ligated via AscI
to a cassette containing a ␤-galactosidase-Neomycin fusion marker (B-Geo)
along with a PGK promoter-driven puromycin resistance marker. The construct (5⬘-arm-B-Geo-3⬘-arm) was then inserted into a NotI/HindIII cut pKO
Scrambler vector (Stratagene, La Jolla, CA) to complete the Nagpa targeting
vector, which display a deletion of coding exons 5–7 (Figure 1). The NotIlinearized targeting vector was electroporated into 129/SvEvBrd (Lex-1) ES
cells. G418/FIAU-resistant ES cell clones were isolated, and their DNA was
analyzed by Southern blot (see Results) by using a 289-base pair 5⬘ external
probe (8/9) (Figure 1), generated by PCR using primers Nagpa-8 [5⬘-TGGAATTCGAATGCGTAATCAA-3⬘] and Nagpa-9 [5⬘-GTCATCGTCGCGGGAAA-3⬘], and a 236-base pair 3⬘ external probe (10/11) (Figure 1), amplified
by PCR using primers Nagpa-10 [5⬘-ACTCAGGCAATGACTCGCTGTG-3⬘]
and Nagpa-11 [5⬘-CCCGCTCCTCTCATAGACGCTA-3⬘]. Two targeted ES
cell clones (1B10 and 1G7) were identified and microinjected into C57BL/6
(albino) blastocysts to generate chimeric animals that were bred to C57BL/6
(albino) females, and the resulting heterozygous offspring were interbred to
produce homozygous Nagpa-deficient mice.

Comprehensive Phenotypic Screen
Wild-type and homozygous null mice were subjected to a comprehensive
battery of phenotype screening exams as described previously (BeltrandelRio
et al., 2003; Zambrowicz et al., 2003). Screening assays included behavioral
tests (such as circadian rhythm, open field, inverted screen, prepulse inhibition of the acoustic startle response, tail suspension, marble burying, and
context trace conditioning), funduscopy and retinal angiography exams,
blood pressure and heart rate measurements, serum chemistries, insulin
levels, glucose tolerance testing, hematology, peripheral blood fluorescenceactivated cell sorting analysis, urinalysis, quantitative magnetic resonance,
dual-energy x-ray absorptiometry scans, computerized axial tomography
scans, microcomputed tomography scans, fertility testing, skin fibroblast
proliferation assays, and pathology.

Histopathology
Immediately after euthanasia, knockout mice and age-matched normal control mice were fixed by cardiac perfusion with 10% neutral buffered Formalin.
Tissues were collected and immersed in 10% neutral buffered Formalin for an
additional 48 h except for the eyes, which were removed and fixed by
immersion in Davidson’s fixative (Poly-Scientific Research, Bay Shore, NY)
overnight at room temperature. All tissues were embedded in paraffin, sectioned at 4 m, and mounted on positively charged glass slides (Superfrost
Plus; Thermo Fisher Scientific). Sections were stained with hematoxylin and
eosin for histopathologic examination.

Enzyme Assays
Lysosomal hydrolase activities were determined by fluorometric enzyme
assays as described previously (Gelfman et al., 2007). In brief, plasma samples
were incubated with 5 mM 4-methylumbelliferyl-coupled specific substrates
(or 1 mM for tissue samples) in a 50 mM citrate buffer containing 0.5% Triton
X-100, pH 4.5, at 37°C. Reactions were stopped by addition of 0.1 M glycineNaOH solution, pH 10.3, and the fluorescence read at 495 nm. For plasma
levels, activities were expressed as nanomoles of hydrolyzed methylumbelliferone per hour per milliliter of plasma.

Percoll Density Gradients
Wild-type and UCE ⫺/⫺ mice that were 2–3 mo of age were anesthetized and
then perfused with phosphate-buffered saline (PBS) to remove blood from
their organs. The brains and livers of these mice were removed and homogenized in 0.25 M sucrose by using a Potter-Elvehjem homogenizer and centrifuged at 1000 ⫻ g for 10 min at 4°C. The pellet was resuspended in 2 ml of
sucrose solution and centrifuged at 1000 ⫻ g for 10 min. The supernatants of
these two steps were pooled (postnuclear fraction) and centrifuged at 35,000
rpm in a 50Ti rotor (Beckman Coulter, Fullerton, CA) for 40 min at 4°C. The
resulting pellet (membrane fraction) was resuspended in 1 ml of sucrose
solution. Then, 500 l of this fraction was loaded on top of an 18% Percoll
solution (18%, vol/vol Percoll [Pharmacia, Uppsala, Sweden], 0.25 M sucrose,
2 mM EDTA and 10 mM Tris-HCl, pH 7.4) and centrifuged at 25,000 rpm in
an SW55Ti rotor (Beckman Coulter) for 40 min at 4°C. Seven fractions were
collected from the top of the gradient. The distribution of four different
lysosomal hydrolases was determined by enzyme assays as described above.

Plasma Lysosomal Hydrolases Clearance Assay
Plasma samples were collected before and 4 h after injection of 200 mg/kg
human serum albumin-mannose into the tail vein of ⬃3-mo-old wild-type
(WT), UCE ⫺/⫺ or GlcNAc-1-phosphotransferase (GNPTAB) ⫺/⫺ mice.
Plasma lysosomal hydrolases activities were then determined as described
above.

Molecular Biology of the Cell

Uncovering Enzyme ⫺/⫺ Mice

Cathepsin D Sorting Assay
Mouse skin fibroblasts were isolated from wild-type and UCE ⫺/⫺ mouse
ears and maintained in ␣-MEM medium containing 20% FCS, 100 g/ml
penicillin, and 100 U/ml streptomycin. Confluent cells (36-mm wells) were
incubated with 1 ml of methionine/cysteine-free ␣-MEM medium containing
⬃600 Ci of TRAN 35S-LABEL methionine/cysteine (MP Biomedicals, Ivrine,
CA) and 10% dialyzed FCS for 1.5 h. Then, a 4-h chase period was initiated by
replacing the labeling medium with 1 ml of ␣-MEM containing 10% FCS and
either 5 mM Man-6-P or 5 mM Man-6-P and 660 g/ml human serum
albumin (HSA)-mannose (⬃10 M) to prevent internalization of secreted
cathepsin D. Chase media were collected and cells were lysed in immunoprecipitation (IP) buffer (0.1 M Tris HCl, pH 8, 0.15 M NaCl, and 1% triton
[TX]-100) containing proteases inhibitors. After centrifugation for 10 min at
14,000 rpm to remove the cell debris, the cell lysates and media were incubated overnight with 60 l of protein A-Sepharose beads that had been
preincubated with 2 l of polyclonal rabbit anti-cathepsin D antibody for 4 h
at 4°C. The next day, the beads were washed once with cold IP buffer and then
three times with buffer containing 0.1 M Tris-HCl, pH 8.0, 1 M NaCl, 1%
TX-100, and 2 mM EDTA, followed by one more time with IP buffer. Immunoprecipitated cathepsin D was released from the beads by boiling 5 min at
100°C in Laemmli’s sample buffer without reducing agent. Samples were
resolved on 10% SDS-polyacrylamide gel electrophoresis (PAGE), which was
fixed in 30% methanol:10% acetic acid for 20 min and incubated with an
amplification solution (Amplify; GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) for 10 min before drying and exposure on a photographic film (ISC BioExpress). Bands were then excised from gel and incubated in formic acid:H2O2 (20%:32%, vol/vol) for 2 d at 55°C. Radioactivity
was measured with a counter (Beckman Coulter LS 6000IC, Fullerton, CA).

Synthesis of N-Acetylglucosaminyl
6-phosphomethylmannose
␣-Methylmannoside (100 mM) was incubated for 48 h at 37°C with 500 ng of
purified GlcNAc-1-phosphotransferase, 19 mM unlabeled UDP-GlcNAc, and
25,000 counts of [3H]UDP-GlcNAc in a final volume of 500 l. Assay buffer
was composed of 0.1 M Tris, pH 7.5, 0.1 M MgCl2, 0.1 M MnCl2, and 2 mg/ml
bovine serum albumin (BSA). The reaction was stopped by boiling 5 min at
100°C. The sample was centrifuged for 10 min at 10,000 ⫻ g, and the supernatant was loaded onto a 25-ml QAE-Sephadex column (2.5 ⫻ 5.0 cm)
equilibrated with 2 mM Tris-HCl, pH 8.0. The column was washed with 50 ml
of equilibration buffer and then eluted with 140 ml of 30 mM NaCl and 2 mM
Tris-HCl, pH 8.0, followed by 30 ml of 2 M NaCl and 2 mM Tris-HCl, pH 8.0.
Fractions (3.5 ml) collected with the first elution buffer that contained tritium
were pooled and lyophilized, and the GlcNAc-P-␣-methylmannose product
was solubilized with water and passed over a P-2 column to remove salt
(Bio-Rad Laboratories, Hercules, CA).

CD- and CI-MPR Affinity Chromatography
Plasma samples (50 –100 l) were diluted 10-fold in CI-MPR column buffer (50
mM imidazole, pH 6.5, 0.15 mM NaCl, and 0.05% TX-100) or CD-MPR column
buffer (same as CI-MPR buffer ⫹ 5 mM ␤-glycerophosphate and 10 mM
MnCl2) and loaded on a CI-MPR affinity column (0.5 mg CI-MPR/ml Affigel-10) or CD-MPR affinity column (0.7 mg CD-MPR/ml Affigel-10) prepared
as described previously (Varki and Kornfeld, 1983; Reddy et al., 2003). Columns were washed with 7 ml of column buffer and then with 7 ml of column
buffer containing 5 mM Glc-6-P, and finally with 5 ml of column buffer
containing 10 mM Man-6-P. One-milliliter fractions were collected and assayed for lysosomal enzyme activity as described above. The percentage of
total hydrolase activity eluted with Man-6-P– containing buffer (receptor
bound fraction) was calculated. When noted, samples were pretreated with
endoglycosidase H (New England Biolabs, Ipswich, MA), Escherichia coli
alkaline phosphatase (Sigma-Aldrich), and/or recombinant uncovering enzyme as follows: plasma samples were incubated with 3000 U of endoglycosidase H for 2 h 30 min at 37°C under nonreducing conditions, with 15 U of
alkaline phosphatase in alkaline phosphatase buffer (5 mM Tris-HCl, pH 8.0,
0.5 mM MgCl2, and 0.5 mM ZnCl2) for 18 h at 37°C and with 18 g of
uncovering enzyme for 2 h at 37°C, respectively.

Purification of Lysosomal Hydrolases from Mouse Plasma
and Endocytosis Assay
Wild-type and UCE ⫺/⫺ acid hydrolases were purified from 4 mL plasma
over a CI-MPR affinity column as described above. The Man-6-P– eluted
fraction was extensively dialyzed against PBS and labeled with 0.5 mCi of 125I
(MP Biomedicals) in iodination tubes (Pierce Chemical, Rockford, IL) following the manufacturer’s instructions. The free iodine was removed using a
PD-10 desalting column (GE Healthcare), and iodinated hydrolases were
purified again over the CI-MPR affinity column. After dialysis against PBS,
the mix of acid hydrolases (200,000 cpm diluted in PBS/1% BSA) was incubated for 2 h at 37°C with mouse L cells either lacking the CI-MPR (clone D9)
or stably transfected with full-length bovine CI-MPR (clone Cc2) (Lobel et al.,
1989). Cells were then rinsed and incubated for 30 s with 0.5 M NaCl and 0.2
M acetic acid, pH 3.5, to release the hydrolases bound to the cell surface.
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Figure 2. Generation of UCE deficient mice. (A) The targeting
vector (engineered as described in Materials and Methods; Figure 1)
was transformed into Lex1 ES cells and the successful insertion of
the cassette into the targeted gene was assessed by Southern blotting. The genomic DNA was digested by either BglII or XhoI, and
the resulting fragment was detected with a 5⬘ external probe or a 3⬘
external probe (see Figure 1), respectively. The 5⬘ probe detected a
6.1-kb band for the wild-type allele and a 13.8-kb band for the
targeted allele. The 3⬘ probe detected a 16.5-kb fragment for the
wild-type allele and a 10.6-kb fragment for the mutant allele. Clones
1B10 and 1G7, containing the mutant allele, were selected for the
injection into C57BL6 blastocysts. The mice derived from clone
1B10* achieved germline transmission. (B) The genotype of the mice
was determined by PCR using primers complementary to sequences
localized in exon 4 (a) and exon 5 (c) that flank the insertion site, and
a primer complementary to the gentrap cassette (b) (see Figure 1).
The first set of primers (a-c, lane 1) allows the amplification of an
⬃260-base pair fragment in the wild-type allele, whereas the second
set (a-b, lane 2) amplifies an ⬃400-base pair fragment in the mutated
allele.

Finally, cells were lysed in 0.1 M NaOH, and the radioactivity that has been
internalized was counted with a counter (Beckman Coulter LS 6000IC). Where
indicated, 125I-hydrolases purified from the UCE ⫺/⫺ plasma were pretreated for 2 h at 37°C with 72 g of uncovering enzyme before incubation
with the cells.

RESULTS
Generation and Phenotypic Screening of the UCE-deficient
Mice
A mouse deficient for the gene that encodes uncovering
enzyme was generated by insertional mutagenesis. The targeting vector (Figure 1) was engineered as described in
Materials and Methods and electroporated into ES cells. Correctly targeted clones were identified and confirmed by
Southern blot analysis (Figure 2A) using a 289-base pair 5⬘
external probe (8/9) and a 236-base pair 3⬘ external probe
(10/11) (Figure 1) to recognize the fragments generated after
digestion of the genomic DNA by BglII or XhoI restriction
enzymes, respectively (Figure 1). The 5⬘ external probe (8/9)
detected a wild-type band of 6.1 kb or a mutant band of 13.8
kb, whereas the 3⬘probe (10/11) detected a wild-type band
of 16.5 kb or a mutant band of 10.6 kb. Two targeted ES cell
clones (1B10 and 1G7) were identified and microinjected into
C57BL/6 (albino) blastocysts to generate chimeric animals
that were bred to C57BL/6 (albino) females, and the result4383
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Table 1. Plasma levels of acid hydrolases in wild-type and UCE ⫺/⫺ mice (n ⱖ 5)
Activity (nmol/ml/h)

␤-Hexosaminidase
␣-Mannosidase
␤-Glucuronidase
␤-Mannosidase
␣-Galactosidase
␤-Galactosidase
␤-Glucocerebrosidase
a

-Fold increase

Wild-type

UCE(⫺/⫺)

UCE(⫺/⫺)

GNPTAB(⫺/⫺)a

272 ⫾ 71
978 ⫾ 153
11 ⫾ 5
171 ⫾ 31
24 ⫾ 6
23 ⫾ 9
49 ⫾ 10

624 ⫾ 121
3045 ⫾ 384
59 ⫾ 18
293 ⫾ 50
45 ⫾ 9
37 ⫾ 8
53 ⫾ 11

2.3⫻
3.1⫻
5.4⫻
1.7⫻
1.9⫻
1.6⫻
1.1⫻

6.7⫻
11.2⫻
9.4⫻
13.9⫻

Data were collected from Gelfman et al. (2007).

ing heterozygous offspring were interbred to produce homozygous Nagpa-deficient mice. The genotyping of the
mice was performed by PCR amplification of genomic DNA
(Figure 2B) using primers that flank the insertion site (primers a and c) and a primer complementary to the genetrap
cassette (b) (Figure 1). The first set of primers allowed the
PCR amplification of an ⬃260-base pair fragment in wildtype but not in UCE ⫺/⫺, whereas the second set of primers
only amplified a band of ⬃400 base pairs from the UCE ⫺/⫺
cDNA containing the genetrap cassette (Figure 2).
On macroscopic examination, UCE-deficient mice were
indistinguishable from wild-type littermates. The UCE-deficient mice were produced in a 1:2:1 Mendelian ratio; were
anatomically normal; and showed normal growth rates, survival, and fertility. Standard serum chemistry and hematology workups were unremarkable (Supplemental Table S1).
Behavioral tests (such as circadian rhythm, open field, inverted screen, prepulse inhibition of the acoustic startle response, tail suspension, marble burying, and context trace
conditioning) gave similar results for both wild-type and
UCE ⫺/⫺ mice. A comprehensive histologic survey of
many tissues (including brain, liver, kidney, heart, lung,
pancreas, spleen, stomach, intestines, salivary glands, chondrocytes, osteoclasts, osteoblasts, retina, and fibroblasts) did
not reveal any detectable abnormalities.
Plasma Levels of Acid Hydrolases Are Elevated in
UCE ⴚ/ⴚ Mice
Mice-deficient in GlcNAc-1-phosphotransferase activity exhibit 7- to 14-fold elevations in their plasma levels of acid
hydrolases, as would be expected when the ability to synthe
size the Man-6-P recognition marker is lost (Gelfman et al.,
2007, Lee et al., 2007) (Table 1). To assess whether the loss of
UCE gives rise to a similar phenotype, the activity of seven acid
hydrolases was measured in the plasma of UCE ⫺/⫺ mice
(Table 1). These assays revealed a 1.6- to 5.4-fold increase in the
plasma level of these enzymes compared with wild-type mice
except for ␤-glucocerebrosidase, which is known to traffic to
lysosomes in a Man-6-P–independent manner (Reczek et al.,
2007).
The steady-state levels of acid hydrolases in the blood are
determined by the rate of secretion from cells along with the
rate of clearance, especially by carbohydrate binding receptors such as the mannose receptor on macrophages and
hepatic endothelial cells (Lee et al., 2002a). In this regard, the
N-linked glycans of the acid hydrolases secreted by cells
deficient in UCE activity would be expected to be mainly of
the high-mannose type (putative mannose receptor ligands),
whereas the N-linked glycans on the acid hydrolases syn4384

thesized by GlcNAc-1-phosphotransferase null cells are
known to be of the complex-type1 that are not recognized by
this receptor (Maynard and Baenziger, 1981). Consequently,
the lower level of acid hydrolases in the blood of UCE ⫺/⫺
mice compared with the GlcNAc-1-phosphotransferase ⫺/⫺
mice could be the result, at least in part, of a greater rate of
clearance by the mannose receptor.
To investigate this possibility, the mannose receptor was
blocked by injection of HSA-mannose into the tail vein of the
various mouse types and the effect on the plasma level of
several acid hydrolases was determined 4 h later. As shown
in Figure 3A, this treatment resulted in a doubling of the
level of ␤-galactosidase and ␤-hexosaminidase in wild-type
mice with no effect on the level of ␤-mannosidase. By contrast, the blockade of the mannose receptor caused a sixfold
increase in the level of ␤-galactosidase, a fourfold increase in
␤-hexosaminidase, and a twofold increase in ␤-mannosidase
activity in the plasma of UCE ⫺/⫺ mice. As predicted, the
HSA-mannose injection had little or no effect on the plasma
levels of the hydrolases in GlcNAc-1-phosphotransferase
(GNPTAB) ⫺/⫺ mice. These results indicate that the acid
hydrolases secreted by cells of the UCE ⫺/⫺ mice are
cleared from the plasma by mannose receptors more rapidly
than the hydrolases secreted by the cells of wild-type mice
or GlcNAc-1-phosphotransferase ⫺/⫺ mice. Therefore, the
measurements of the steady-state levels of the acid hydrolases underestimate the rate of secretion by UCE ⫺/⫺ cells
relative to that of the other types of mice. When this factor is
taken into account, the hypersecretion of some acid hydrolases by UCE ⫺/⫺ cells approaches that observed with
GlcNAc-1-phosphotransferase negative cells, especially for
␤-hexosaminidase (Figure 3B).
UCE ⴚ/ⴚ Fibroblasts Hypersecrete Cathepsin D
To directly determine the degree of acid hydrolases secretion by UCE ⫺/⫺ cells, skin fibroblasts were isolated and
cathepsin D sorting was followed by pulse/chase analysis.
Wild-type and UCE ⫺/⫺ cells were incubated with [35S]methionine/cysteine for 1.5 h followed by a chase of 4 h in
unlabeled medium containing 5 mM of Man-6-P to inhibit
reinternalization of the secreted cathepsin D by the CI-MPR
(Figure 4A) or 5 mM of Man-6-P and 10 M HSA-mannose
1

The difference in oligosaccharide structure arises because the presence of Man-6-P residues on high-mannose glycans prevents processing to complex type structures. Therefore, hydrolases that lack
Man-6-P (as occurs in GlcNAc-1-phosphotransferase null cells) are
processed to complex-type units.
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species detected in the cell lysate, which results from the
intralysosomal processing of the cathepsin D precursor into
the intermediate form. The fibroblasts of the UCE ⫺/⫺ mice
also sorted the majority of the cathepsin D to lysosomes but,
in contrast to the wild-type cells, secreted readily detectable
amounts of the 47-kDa proform into the medium. When the
bands representing cathepsin D were excised, solubilized,
and counted, the secretion of cathepsin D by the UCE ⫺/⫺
cells was found to be twice that of wild-type cells (21 ⫾ 4 vs.
10 ⫾ 3%; p ⬍ 0.001), but much less than the 63% secretion
observed GlcNAc-1-phosphotransferase ⫺/⫺ fibroblasts
(Lee et al., 2007). Similar results were obtained when HSAmannose was added to the chase media (14 ⫾ 3% of cathepsin D secreted from WT cells and 24 ⫾ 3% from UCE ⫺/⫺
cells) (Figure 4B), suggesting that reinternalization of the
secreted UCE ⫺/⫺ acid hydrolases by the mannose receptor
was negligible.
Figure 3. UCE ⫺/⫺ plasma acid hydrolases are rapidly cleared by
the mannose receptor. (A) HSA-mannose (200 mg/kg) was injected
in the tail vein of ⬃3-mo-old wild-type, UCE ⫺/⫺ or GNPTAB
⫺/⫺ mice. The activities of ␤-galactosidase (␤-gal), ␤-mannosidase
(␤-mann), and ␤-hexosaminidase (␤-hex) were measured in plasma
samples collected before treatment (starting levels) and 4 h after
injection. Relative increases (-fold) compared with starting levels
(set to 1) are shown on the graph. Wild-type and UCE ⫺/⫺ mice,
n ⫽ 4; GNPTAB ⫺/⫺ mice, n ⫽ 2. **p ⬍ 0.001, *p ⬍ 0.01. (B) Effect
of the mannose receptor blockade on plasma acid hydrolases levels
was calculated. Values represent the increases (-fold) in plasma
␤-gal, ␤-mann, or ␤-hex activities observed 4 h after injection of 200
mg/kg HSA-Man over wild-type basal levels (noninjected).

to block both the CI-MPR and the mannose receptor (Figure
4B). The cathepsin D was immunoprecipitated from cell
lysates and chase media, subjected to SDS-PAGE, and visualized by autoradiography. As shown in Figure 4A, the
wild-type fibroblasts sorted almost all the newly synthesized cathepsin D to lysosomes, as indicated by the 43-kDa

Figure 4. UCE ⫺/⫺ mouse skin fibroblasts hypersecrete cathepsin
D. (A) Primary skin fibroblasts isolated from wild-type or UCE ⫺/⫺
mice were incubated for 90 min with TRAN 35S-LABEL methionine/cysteine containing media (pulse) and then for 4 h in unlabeled media (chase) containing 5 mM of Man-6-P. Cathepsin D was
immunoprecipitated from cell lysates (C) and media (M) collected at
the end of the 4-h chase period and resolved on 10% SDS-PAGE.
Signals were visualized by autoradiography. A representative experiment (of a total of 3 for WT and 6 for UCE ⫺/⫺, with fibroblasts
isolated from separate mice) is shown. Arrows indicate the proform
of cathepsin D (⬃47 kDa) and cathepsin D intermediate form (43
kDa). (B) Fibroblasts were incubated for 90 min with TRAN
35
S-LABEL methionine/cysteine containing media and then for 4 h
in unlabeled chase media containing 5 mM Man-6-P and 660 g/ml
HSA-mannose. Cathepsin D was immunoprecipitated as described
in A (WT and UCE ⫺/⫺, n ⫽ 3).
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Acid Hydrolases Are Efficiently Targeted to Lysosomes in
Brain and Liver of UCE ⴚ/ⴚ Mice
The ability of the acid hydrolases to reach lysosomes in the
absence of UCE activity was further investigated using brain
and liver from mice that had been perfused with PBS to
remove blood from their organs. Table 2 shows that the acid
hydrolase content of these organs from UCE ⫺/⫺ mice was
indistinguishable from that of the wild-type mice. To determine whether the hydrolases were actually in lysosomes,
membrane fractions of brain and liver were fractionated on
18% self-forming Percoll density gradients, which separate
dense lysosomes (bottom of the gradient) from the other
subcellular organelles that concentrate in the lightest fractions of the gradient. The activity of four acid hydrolases
was measured in the seven fractions collected after centrifugation and expressed as a percentage of the total activity
recovered. Figure 5B shows that the distribution of ␤-galactosidase on the gradient was almost identical in the brain
from both wild-type and UCE ⫺/⫺ mice, with a strong
concentration in the dense lysosome fraction. Similar results
were observed for ␤-mannosidase, ␤-hexosaminidase, and
␤-glucuronidase. The acid hydrolase levels in this last fraction were slightly decreased in the UCE ⫺/⫺ liver compared with wild-type (i.e., ␤-galactosidase; Figure 5A). Together, these findings indicate that acid hydrolase targeting
to lysosomes in the brain of UCE ⫺/⫺ mice is equivalent to
that of wild-type mice and only slightly, if at all, impaired in
the liver.
Acid Hydrolases in UCE ⴚ/ⴚ Mouse Plasma Bind to
CI-MPR In Vitro
In the absence of UCE activity, lysosomal hydrolases would
be expected to bear N-linked high mannose glycans with
GlcNAc-P-Man diesters unless the GlcNAc residues are removed by an alternative pathway. To determine the state of
the phosphorylated glycans on the acid hydrolases produced by UCE ⫺/⫺ cells, we analyzed the binding of
plasma acid hydrolases to a CI-MPR affinity column under
various conditions. In brief, plasma samples (50 –100 l)
were diluted with buffer, loaded onto the column, and the
amount of acid hydrolase (% of starting material) that
passed through the column, bound nonspecifically, and
eluted with Glc-6-P or bound specifically and required Man6-P for elution, was determined. The results for three acid
hydrolases are shown in Table 3A. (NB. The total levels of
the hydrolases in the plasma of the WT and UCE ⫺/⫺ mice
are given in Table 1.) It is apparent that a fraction of all three
hydrolases from both wild-type and UCE ⫺/⫺ mouse plasmas bound specifically to the CI-MPR affinity column, but
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Table 2. Levels of acid hydrolases in the brain and liver of wild-type and UCE ⫺/⫺ mice
Activity (nmol/ml/h)

␤-Hexosaminidase
␤-Glucuronidase
␤-Mannosidase
␤-Galactosidase

Wild-type brain (n ⫽ 4)

UCE ⫺/⫺ brain (n ⫽ 6)

Wild-type liver (n ⫽ 4)

UCE ⫺/⫺ liver (n ⫽ 4)

28.0 ⫾ 7.3
6.0 ⫾ 1.3
4.6 ⫾ 1.6
9.4 ⫾ 3.3

28.1 ⫾ 6.5
5.9 ⫾ 1.1
5.7 ⫾ 4.9
12.1 ⫾ 3.4

15.7 ⫾ 5.7
34.1 ⫾ 12.7
14.9 ⫾ 8.1
20.1 ⫾ 7.9

22.1 ⫾ 4.9
40.5 ⫾ 26.1
10.5 ⫾ 7.2
26.9 ⫾ 10.0

the extent of binding of the ␤-mannosidase and ␤-glucuronidase varied substantially between wild-type and UCE ⫺/⫺.
Thus, ␤-mannosidase from UCE ⫺/⫺ plasma bound 9%
compared with 50% for the wild-type enzyme and ␤-glucuronidase from the UCE ⫺/⫺ and wild-type plasma samples
bound 79 and 49%, respectively. Similar amounts of ␤-hexosaminidase binding (12%) were observed with both types

Figure 5. The subcellular distribution of acid hydrolases in the
brain and liver of wild-type and UCE ⫺/⫺ mouse is similar in a
self-forming Percoll density gradient. Wild-type or UCE ⫺/⫺ liver
(A) and brain (B) were homogenized in isotonic sucrose with a
Potter-Elvehjem homogenizer and centrifuged at 1000 ⫻ g to prepare a postnuclear supernatant (PNS). The PNS was subjected to
centrifugation at 35,000 rpm in a 50Ti rotor for 40 min at 4°C to
obtain a membrane fraction, which was resuspended in isotonic
sucrose and loaded on top of a 18% Percoll solution. Self-forming
gradients were generated by centrifugation at 25,000 rpm in a
SW55Ti rotor for 40 min at 4°C. Seven fractions were collected from
the top (low density) to the bottom (densest fraction), and acid
hydrolase content was determined by enzyme assays. Graphs represent the distribution of ␤-galactosidase in WT (n ⫽ 2) or UCE
⫺/⫺ (n ⫽ 2) liver (A) and brain (B), expressed as a percentage of the
total activity recovered in each fraction. Similar distributions were
observed for ␤-hexosaminidase, ␤-glucuronidase, and ␤-mannosidase.
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of plasma. The binding of all three WT and UCE ⫺/⫺
hydrolases to the affinity column was mediated by residues
exposed on high-mannose sugar chains, because binding was
abolished when samples were pretreated with endoglycosydase H (Table 3A, Endo H). It should be noted that the hydrolases in the plasma may originate by direct secretion from cells
or by release from lysosomes in which they would have been
exposed to glycosidase and phosphatase activities that have
the ability to excise the GlcNAc and phosphate residues from
GlcNAc-P-Man and Man-6-P, respectively (Varki and Kornfeld, 1980, Sun et al., 2008). The ratio of the acid hydrolases that
are directly secreted via the Golgi (with intact oligosaccharide
chains) compared with the acid hydrolases that are released
after traffic through the lysosome may differ between the wildtype and UCE ⫺/⫺ hydrolases. Consequently, the binding
percentages of the wild-type and UCE ⫺/⫺ acid hydrolases to
the CI-MPR affinity column cannot be used to compare their
relative affinity for the receptor in vivo.
Treatment of the wild-type plasma with alkaline phosphatase (Table 3A, Alk.phos.) decreased binding of the three
hydrolases by 67–90%, indicating that the binding was
mostly mediated by Man-6-P monoesters. By contrast, the
alkaline phosphatase treatment had no effect on the binding of
␤-mannosidase and ␤-glucuronidase present in the UCE ⫺/⫺
mouse plasma, consistent with these hydrolases containing
glycans with Man-6-P diesters. This conclusion was supported by the finding that the binding of these two hydrolases to the CI-MPR affinity column was enhanced after
treatment with purified UCE (71% binding for ␤-mannosidase and 88% binding for ␤-glucuronidase). When UCE
treatment was followed by incubation with alkaline phosphatase, binding of these two hydrolases to the column was
greatly decreased, as expected if the UCE was converting
diesters to monoesters that are susceptible to alkaline phosphatase action. The ␤-hexosaminidase in the UCE ⫺/⫺
mouse plasma behaved as if it contained both Man-6-P
monoesters and diesters. Thus, alkaline phosphatase treatment decreased binding from 12 to 3%, whereas UCE treatment increased the binding to 36%. One possibility is that the
␤-hexosaminidase consists of molecules directly secreted by
cells and molecules that are derived from lysosomes (uncovered by lysosomal ␣-N-acetylglucosaminidase). Treatment of
the acid hydrolases in wild-type mouse plasma with UCE did
not enhance binding to the CI-MPR affinity column, demonstrating that these enzymes lack GlcNAc-P-Man diesters.
In a second approach, the plasma samples were loaded
onto the affinity column in the presence of either 200 M
Man-6-P or 10 mM GlcNAc-P-␣-methylmannose (Table 3B).
Binding of the acid hydrolases from wild-type mouse
plasma was strongly inhibited by the Man-6-P (50 –10% for
␤-mannosidase, 49 –12% for ␤-glucuronidase, and 12– 0% for
␤-hexosaminidase), whereas the GlcNAc-P-␣-methylmannose had no effect, consistent with these hydrolases bearing
Man-6-P monoesters exclusively. By contrast, the binding of
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Table 3. Percentage of plasma acid hydrolases that specifically bind to a CI-MPR affinity column (1 representative experiment, n ⫽ 3)
A. Effect of endoglycosydase H, alkaline phosphatase (Alk.phos.), and uncovering enzyme treatment
UCE ⫺/⫺

Wild-type
Untreated

Endo Ha

Alk.phos.

UCE

UCE ⫹
Alk.phos.

Untreated

Endo Ha

Alk.phos.

UCE

UCE ⫹
Alk.phos.

50
49
12

0
0
3

12
5
4

41
47
8

2
8
1

9
79
12

0
0
1

9
77
3

71
88
36

14
34
3

␤-Mannosidase
␤-Glucuronidase
␤-Hexosaminidase

B. Inhibition of binding by Man-6-P (M6P) or GlcNAc-P-␣-methylmannose
UCE ⫺/⫺

Wild-type

Untreated

200 M
M6P

10 mM
GlcNAc-P-␣methylman

1 mM
M6P

50
49
12

10
17
0

49
50
14

0
11
3

␤-Mannosidase
␤-Glucuronidase
␤-Hexosaminidase
a

Untreated

200 M
M6P

10 mM
GlcNAc-P-␣methylman

1 mM
M6P

200 M M6P ⫹ 10
mM GlcNAc-P-␣methylman

9
79
12

14
82
6

1
50
5

1
65
4

1
28
3

n ⫽ 2.

the ␤-mannosidase and ␤-glucuronidase from UCE ⫺/⫺
mouse plasma was not affected by 200 M Man-6-P but was
inhibited by the GlcNAc-P-␣-methylmannose (9 –1% for the
␤-mannosidase and 79 –50% for the ␤-glucuronidase), indicative of the presence of Man-6-P diesters on these hydrolases. Binding of the ␤-hexosaminidase from the UCE ⫺/⫺
mouse plasma to the affinity column was partially inhibited
by both Man-6-P and GlcNAc-P-␣-methylmannose, consistent with it containing both Man-6-P monoesters and diesters. Note that 1 mM Man-6-P inhibited binding of both
wild-type and UCE ⫺/⫺ hydrolases, although UCE ⫺/⫺
␤-glucuronidase binding remained higher (65%) than when
inhibited by GlcNAc-P-␣-methylmannose (50%). A combination of both Man-6-P (200 M) and GlcNAc-P-␣-methylmannose (10 mM) decreased the binding of this enzyme to 28%.
Taken together, these data strongly indicate that the
acid hydrolases of wild-type mice contain Man-6-P monoesters, whereas the hydrolases of the UCE ⫺/⫺ mice contain GlcNAc-P-Man diesters and have a decreased affinity for
the CI-MPR compared with monoesters-containing enzymes
(i.e., the enhanced binding measured after UCE treatment).
Acid Hydrolases in UCE ⴚ/ⴚ Mouse Plasma Fail to Bind
to CD-MPR In Vitro
In a study of the ligand-binding properties of the CI-MPR
and the CD-MPR, it was found that the CI-MPR binds
GlcNAc-P-␣-methylmannose with low affinity (Kd of 1 ⫻
10⫺4 vs. 7 ⫻ 10⫺6 for Man-6-P), whereas binding of this
diester to the CD-MPR was below detectable level (Kd ⬎ 4 ⫻
10⫺3) (Tong and Kornfeld, 1989). More recently, surface
plasmon resonance studies demonstrated that the CD-MPR
has little affinity for acid ␣-glucosidase when it only exposes
GlcNAc-P-Man diesters (Chavez et al., 2007). To determine
whether UCE ⫺/⫺ mouse plasma acid hydrolases that bear
phosphodiesters are able to bind to the CD-MPR, plasma
samples from wild-type and UCE ⫺/⫺ mice were passed
over a CD-MPR affinity column and the binding of three
acid hydrolases was measured. Although 6% of the ␤-mannosidase, 13% of the ␤-glucuronidase, and 6% of the ␤-hexVol. 20, October 15, 2009

osaminidase from wild-type plasma bound specifically to the
affinity column, ⬍2% of these hydrolases from UCE ⫺/⫺
mouse plasma bound (Table 4). This is consistent with the
CD-MPR not being able to bind Man-6-P diesters.
Acid Hydrolases of UCE ⴚ/ⴚ Mouse Plasma Are Poorly
Internalized by Mouse L Cells Expressing the CI-MPR
Because the CI-MPR affinity chromatography experiments
use columns with high levels of bound CI-MPR, we wanted
to determine the ability of acid hydrolases containing Man6-P diesters to bind to the receptor under more physiological
conditions. To do this, acid hydrolases were purified from
the plasma of wild-type and UCE ⫺/⫺ mice on the CI-MPR
affinity column, labeled with 125I and incubated with mouse
L cells that either lack or express the CI-MPR. The radioactivity internalized after incubation of the WT or UCE ⫺/⫺
plasma 125I-hydrolases with the cells (CTRL cells or
CI-MPR– expressing cells) for a 2-h period at 37°C was determined and the nonspecific uptake by the receptor-deficient cells was set to 1 (Figure 6). We selected plasma as the
source for the hydrolases based on the finding that the
plasma hydrolases of the UCE ⫺/⫺ mice still contained
GlcNAc-P-Man diesters (Table 3). The acid hydrolases in the
tissues of these mice are mainly localized to lysosomes
where they are exposed to ␣-N-acetylglucosaminidase that
cleaves the GlcNAc and thereby converts the diesters to
monoesters. In tissues others than the brain, the Man-6-P
residues are then hydrolyzed by a phosphatase to give rise

Table 4. Binding of wild-type or UCE ⫺/⫺ plasma acid hydrolases
to a CD-MPR affinity column (1 representative experiment, n ⫽ 3)

␤-Mannosidase
␤-Glucuronidase
␤-Hexosaminidase

Wild-type

UCE ⫺/⫺

6
13
6

⬍2
⬍2
⬍2
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Figure 6. UCE ⫺/⫺ plasma acid hydrolases are poorly internalized
by CI-MPR– expressing mouse L cells. Plasma acid hydrolases (wildtype or UCE ⫺/⫺) were enriched over a CI-MPR affinity column and
then labeled with 125I and incubated with D9 cells lacking CI-MPR
(CTRL cells, n ⫽ 3) or Cc2 cells stably transfected with bovine CI-MPR
(CI-MPR cells, n ⫽ 3). The mix of acid hydrolases (200,000 cpm) was
added in a 36-mm well and incubation was performed for 2 h at 37°C.
The amount of radioactivity internalized by CTRL cells (⬍0.5% of total)
was set to 1 (nonspecific uptake), and the amount of 125I-hydrolases
specifically internalized by CI-MPR cells was expressed as relative
uptake over CTRL cells. One representative experiment is shown.
Where indicated, UCE ⫺/⫺ 125I-labeled hydrolases were treated for
2 h at 37°C with uncovering enzyme before incubation with the cells
(one representative experiment with n ⫽ 2).

to neutral species (Sun et al., 2008). Therefore, plasma is the
best source for “native” enzymes. Although the relative
levels of the various acid hydrolases differed between the
plasmas of the WT and UCE ⫺/⫺ animals (Table 1) along
with their efficiency of binding to the CI-MPR affinity column, the purified hydrolases represented the molecules
with the highest affinity for the CI-MPR and therefore had
the highest likelihood of being internalized by the CI-MPR–
expressing cells. Our results show that the CI-MPR– expressing L cells internalized the acid hydrolases of wild-type
plasma at 3 times the rate of the receptor-deficient cells. The
acid hydrolases of the UCE ⫺/⫺ plasma were internalized
about equally by both types of L cells. Pretreatment of the
UCE ⫺/⫺ sample with purified UCE resulted in increased internalization by the CI-MPR– expressing L cells.
As with our in vitro binding studies, this result shows that
conversion of phosphomannose diesters to monoesters
significantly increases the affinity of UCE ⫺/⫺ hydrolases
for the CI-MPR. It should be noted that in this experiment
the amount of wild-type hydrolases internalized by the
CI-MPR– expressing cells was quite low (⬍0.5% of total).
Consequently, this assay may not be sufficiently sensitive
to detect GlcNAc-P-Man– dependent internalization of the
UCE ⫺/⫺ hydrolases, as uptake of theses enzymes would
be expected to be less efficient compared with hydrolases
with Man-6-P monoesters. Because cathepsin D was sorted
to lysosomes with good efficiency in the UCE ⫺/⫺ fibroblasts (Figure 4), hydrolases containing Man-6-P diesters
must be able to bind to the CI-MPR under the conditions of
the TGN environment.
DISCUSSION
The data presented here demonstrate that inactivation of the
gene that encodes UCE in mice results in an inability to
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convert GlcNAc-P-Man diesters to monoesters on newly
synthesized acid hydrolases. This finding indicates that UCE
accounts for virtually all of the uncovering activity in the
Golgi. The small amount of Man-6-P monoesters found on the
␤-hexosaminidase present in the plasma of the UCE ⫺/⫺
animals probably is the result of cleavage of the GlcNAc in the
lysosome by ␣-N-acetylglucosaminidase (Varki and Kornfeld,
1980), followed by the release of the lysosomal content into the
circulation. Whether the phosphodiesters on ␤-mannosidase
and ␤-glucuronidase are less sensitive to the action of the
lysosomal ␣-N-acetylglucosaminidase or whether a smaller
proportion of these enzymes originates from the lysosomal
compartment is unknown.
The failure of the UCE ⫺/⫺ cells to convert the Man-6-P
diesters to monoesters resulted in the hypersecretion of the
acid hydrolases into the plasma, although the steady-state
levels of these enzymes in the plasma did not reach the
levels observed in mice that lack GlcNAc-1-phosphotransferase and therefore are completely unable to synthesize
Man-6-P on their acid hydrolases. There are several reasons
for this difference. First, the hydrolases in the plasma of the
UCE ⫺/⫺ mice are rapidly cleared by the mannose receptor,
whereas the hydrolases of the GlcNAc-1-phosphotransferase null mice fail to bind to this receptor. When this difference in clearance rate is taken into account, the degree of
hypersecretion of some acid hydrolases by UCE ⫺/⫺ cells
approaches that of the GlcNAc-1-phosphotransferase null cells.
Second, the acid hydrolases synthesized by the UCE ⫺/⫺ cells
bind to the CI-MPR, albeit with a lower affinity compared
with Man-6-P monoesters, whereas the hydrolases of the
GlcNAc-1-phosphotransferase null mice fail to interact with
this receptor. We postulate that the weak binding of the acid
hydrolases of the UCE ⫺/⫺ mice to the CI-MPR diverts
some of the newly synthesized acid hydrolases from the
secretory pathway to the endosome/lysosome targeting
pathway. This is illustrated by the UCE ⫺/⫺ skin fibroblasts
that target cathepsin D to lysosomes much more efficiently
than occurs in GlcNAc-1-phosphotransferase null fibroblasts. However, it should be pointed out that the acid hydrolases of the UCE ⫺/⫺ mice do not bind to the CD-MPR. It has
been reported that although most cell types express both the
CI-MPR and the CD-MPR, some cell types such as Kupffer
cells, selectively express the CD-MPR (Waguri et al., 2001).
Such cell types are candidates for hypersecretion of acid hydrolases in the UCE ⫺/⫺ mice plasma.
The basis for the weak binding of the acid hydrolases
carrying GlcNAc-P-Man diesters to the CI-MPR has been
identified by recent studies of this receptor. The CI-MPR
contains 15 repeating domains in its extracytoplasmic region
and it has been established that domains 3 and 9 bind
Man-6-P monoesters with high affinity (for review, see
Dahms et al., 2008). A low-affinity binding site for Man-6-P
was also identified within domain 5 (Reddy et al., 2004).
Recently, it was reported that domain 5 has a preference for
GlcNAc-P-Man diesters over Man-6-P monoesters, although
the binding of this ligand is also of low affinity compared
with the binding of Man-6-P to domain 9 (Chavez et al.,
2007). This was shown using ␣-acid glucosidase containing
N-linked oligosaccharides with either GlcNAc-P-Man diesters or Man-6-P monoesters. In this assay, the binding of
␣-acid glucosidase containing Man-6-P diesters to domain 5
was inhibited by GlcNAc-P-␣-methylmannose (Ki ⫽ 1 mM),
whereas the Ki for Man-6-P was 14 mM. These findings
indicate that the interaction of the acid hydrolases of the
UCE ⫺/⫺ mice with the CI-MPR is likely mediated via
binding to domain 5 of the receptor. Nevertheless, a minor
contribution of another binding domain to the overall bindMolecular Biology of the Cell
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ing avidity of the hydrolases to the CI-MPR cannot be ruled
out. The hydrolases that were analyzed in our study have
two or more N-linked glycans, each of which can contain
one or two GlcNAc-P-Man residues. For example, mouse
␤-glucuronidase is a tetramer with three N-linked glycans
per monomer, most of which are phosphorylated (Shipley et
al., 1993), which could explain why this hydrolase binds so
efficiently to the CI-MPR affinity column. Interestingly, the
binding of the ␤-glucuronidase in the UCE ⫺/⫺ plasma to
the CI-MPR was more inhibited by a mixture of Man-6-P
and GlcNAc-P-␣-methylmannose than by GlcNAc-P-␣methylmannose alone. This observation supports the possibility that a weak binding of some N-glycans to domains 3
and/or 9 of the CI-MPR may strengthen/stabilize the interaction of the UCE ⫺/⫺ enzymes with the CI-MPR, although
the involvement of domain 9 seems highly unlikely because
it does not bind the diester-enriched form of ␣-acid glucosidase (Chavez et al., 2007).
Although the UCE ⫺/⫺ mice exhibit significant missorting of their newly synthesized acid hydrolases, this defect
was not accompanied by the development of any of the
tissue abnormalities seen in the GlcNAc-1-phosphotransferase null mice (Gelfman et al., 2007; Vogel et al., 2009). These
mice are small, develop severe retinal degeneration and
have striking inclusions in the secretory cells of the exocrine
glands that are readily detectable at the light microscope
level (Gelfman et al., 2007; Vogel et al., 2009). The most likely
explanation for this difference is that the weak binding of the
newly synthesized acid hydrolases to the CI-MPR in UCE ⫺/⫺
cells leads to the targeting of sufficient amounts of acid
hydrolases to lysosomes in critical cell types to prevent
pathological changes. These findings indicate that it is unlikely that UCE deficiency in humans would result in a
phenotype as deleterious as occurs in patients with mucolipidosis type II and III.
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